SPINRAZA STORIES/CHILDREN ON SPINRAZA

People with later-onset SMA treated with SPINRAZA showed significant improvements in motor function

Hear from SPINRAZA families

Some individuals featured may be participating in Biogen clinical trials.

have been treated with
SPINRAZA worldwide

there’s someone from almost every
age group who has taken
SPINRAZA

have been treated with SPINRAZA

*Based on commercial patients and early access patients receiving treatment with SPINRAZA worldwide as of June 2024.

Based on patients receiving treatment with SPINRAZA in the US as of May 2024.

SPINRAZA (12 mg) clinical studies included patients from 3 days to 16 years of age at first dose and did not include sufficient numbers of subjects aged 65 and older to determine whether they respond differently from younger patients. Pivotal studies did not include adult patients.

Find more information about SMA